PUBLIC EMPLOYEES RETIREMENT ASSOCIATION OF COLORADO - ZIOPHARM ONCOLOGY INC ownership

ZIOPHARM ONCOLOGY INC's ticker is ZIOP and the CUSIP is 98973P101. A total of 142 filers reported holding ZIOPHARM ONCOLOGY INC in Q2 2019. The put-call ratio across all filers is 1.04 and the average weighting 0.1%.

Quarter-by-quarter ownership
PUBLIC EMPLOYEES RETIREMENT ASSOCIATION OF COLORADO ownership history of ZIOPHARM ONCOLOGY INC
ValueSharesWeighting
Q1 2022$26,000
-39.5%
39,5650.0%0.00%
Q4 2021$43,000
-40.3%
39,5650.0%0.00%
Q3 2021$72,000
-30.8%
39,5650.0%0.00%
Q2 2021$104,000
-26.8%
39,5650.0%0.00%
-100.0%
Q1 2021$142,000
+42.0%
39,5650.0%0.00%
Q4 2020$100,0000.0%39,5650.0%0.00%
-100.0%
Q3 2020$100,000
-23.1%
39,5650.0%0.00%0.0%
Q2 2020$130,000
+34.0%
39,5650.0%0.00%0.0%
Q1 2020$97,000
-26.5%
39,565
+41.9%
0.00%0.0%
Q4 2019$132,000
+10.9%
27,8850.0%0.00%0.0%
Q3 2019$119,000
-27.0%
27,8850.0%0.00%0.0%
Q2 2019$163,000
+52.3%
27,8850.0%0.00%0.0%
Q1 2019$107,000
+105.8%
27,8850.0%0.00%
Q4 2018$52,000
-41.6%
27,8850.0%0.00%
-100.0%
Q3 2018$89,000
+6.0%
27,8850.0%0.00%0.0%
Q2 2018$84,000
-22.9%
27,8850.0%0.00%0.0%
Q1 2018$109,000
-5.2%
27,8850.0%0.00%0.0%
Q4 2017$115,000
-32.7%
27,8850.0%0.00%0.0%
Q3 2017$171,000
-1.2%
27,8850.0%0.00%0.0%
Q2 2017$173,000
-2.3%
27,8850.0%0.00%0.0%
Q1 2017$177,000
+18.8%
27,8850.0%0.00%0.0%
Q4 2016$149,000
-5.1%
27,8850.0%0.00%0.0%
Q3 2016$157,000
+2.6%
27,8850.0%0.00%0.0%
Q2 2016$153,000
-26.1%
27,8850.0%0.00%
-50.0%
Q1 2016$207,000
+64.3%
27,885
+83.6%
0.00%
+100.0%
Q4 2015$126,000
-8.0%
15,1840.0%0.00%0.0%
Q3 2015$137,000
-24.7%
15,1840.0%0.00%0.0%
Q2 2015$182,00015,1840.00%
Other shareholders
ZIOPHARM ONCOLOGY INC shareholders Q2 2019
NameSharesValueWeighting ↓
MSD Partners, L.P. 10,986,258$20,544,0001.80%
Third Security, LLC 4,364,080$8,161,0001.11%
MILLER VALUE PARTNERS, LLC 9,264,700$16,617,0000.75%
Sargent Investment Group, LLC 188,950$353,0000.22%
Chessman Wealth Strategies RIA 72,050$135,0000.14%
Ibex Investors LLC 403,650$755,0000.12%
Old West Investment Management, LLC 223,319$417,0000.11%
PIPER SANDLER & CO. 34,222$64,0000.07%
Virtus ETF Advisers LLC 102,888$192,0000.03%
G&S Capital LLC 18,000$34,0000.03%
View complete list of ZIOPHARM ONCOLOGY INC shareholders